Remove Drug Development Remove Generic Medicine Remove Packaging
article thumbnail

STAT+: ‘Like playing the lottery’: A mixed picture for laid-off life sciences workers in Massachusetts

STAT

The state’s biotech scene   exploded in the mid-2010s and early in the pandemic as exuberant investors disregarded the high failure rate in drug development and bet on buzzy technologies such as gene editing and messenger RNA vaccines. “But I was confident I was going to find something else.” Absolutely.”

Vaccines 330
article thumbnail

Can technology help diversify clinical trials?

pharmaphorum

It is important for all digital healthcare tools to comply with national and supranational data protection legislation governing the processing of patient health data, where legislation falls outside the scope of medicines regulations. As a Non-Clinical Assessor at MHRA he assessed non-clinical data packages for new and generic medicines.